Health Care • Medical/Nursing Services
$4.75 ▼ -0.01
(-0.21%)
MKT CAP: $420.2M • VOL: 1.25M
52W L $4 52W H $7
SRTA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $197.1M | $146.8M | $225.2M |
| YoY Revenue Growth % | +34.3% | -34.8% | — |
| Gross Profit | $41.1M | $29.6M | — |
| Gross Margin % | 20.9% | 20.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$22.4M | -$22.5M | -$68.1M |
| Operating Margin % | -11.3% | -15.3% | -30.3% |
| Net Income (GAAP) | $41.3M | -$27.3M | -$56.1M |
| EBITDA (Normalized) | -$14.7M | $2.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$48.9M | -$2.5M | -$32.3M |
| Capital Expenditures (CapEx) | $9.6M | $30.9M | — |
| Free Cash Flow (FCF) | -$58.5M | -$33.4M | -$32.3M |
| FCF Margin % | -29.7% | -22.7% | -14.4% |
| Return on Invested Capital (ROIC %) | -7.1% | -8.7% | — |
| Cash & Short-Term Equivalents | $31.0M | $18.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $279.1M | $221.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SRTA.